Cellective BioTherapy Company
Cellective BioTherapy develops novel cellular and monoclonal antibody-based platforms to treat cancer, autoimmunity, and immunodeficiency.
Technology:
Cell-based gene therapy
Industry:
Geroscience, Private
Headquarters:
Raleigh, North Carolina, United States
Zip:
1-10
Founded Date:
2015-04-01
Employees Number:
1-10
Funding Status:
Seed
Acquisitions Number:
2
Investors Number:
2
Total Funding:
2500000
Estimated Revenue:
Less than $1M
Last Funding Date:
2015-06-12
Last Funding Type:
Angel
Register and Claim Ownership